Stay updated on Magrolimab Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combo in AML Clinical Trial page.

Latest updates to the Magrolimab Combo in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision tag on the page updated from v3.6.3 to v3.6.4. This indicates a small metadata update to the page version.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays the updated revision tag, indicating a new release of the page template rather than any changes to the study details.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page shows a newer revision number, replacing the previous one. This likely reflects an internal template or CMS update and does not indicate changes to the study content.SummaryDifference0.0%

- Check56 days agoChange DetectedNew user guidance sections were added and a recruitment status line indicates that enrollment has ended. The Intervention/Treatment header formatting was updated and a site revision note (Revision: v3.6.0) was added.SummaryDifference0.2%

- Check63 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, signaling a new release of the page content.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page revision indicator updated from v3.5.3 to v3.5.4, representing a new build of the page. This reflects a small version update of the page rather than a content change.SummaryDifference0.0%

Stay in the know with updates to Magrolimab Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in AML Clinical Trial page.